Showing results (191-200 of 224) with videos related to
Sort By:
Pageof 23
Journal of Virology|September 18, 2025
Multimodal characterization of the responsiveness of eight hepatitis D virus genotype isolates to interferon-alpha treatmentYibo Ding, Qiudi Li, Yunlu Sha, et al.Journal of Virology|May 23, 2025
Reconstitution of interferon regulatory factor 7 expression restores interferon beta induction in Huh7 cellsAndreas Betz, Hao-En Huang, Zuguang Gu, et al.Hepatology (Baltimore, Md.)|April 9, 2014
Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolismNicola Oehler, Tassilo Volz, Oliver D Bhadra, et al.Cells|October 15, 2024
Liver Fibrosis Is Enhanced by a Higher Egg Burden in Younger Mice Infected with S. mansoniHeike Müller, Jan K Straßmann, Anne S Baier, et al.Elife|July 24, 2019
Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptideDominik Witzigmann, Philipp Uhl, Sandro Sieber, et al.Frontiers in Immunology|May 7, 2024
CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cellsSophia Schreiber, Lisa S Dressler, Eva Loffredo-Verde, et al.Journal of Medical Virology|May 28, 2024
Development of a single-domain antibody to target a G-quadruplex located on the hepatitis B virus covalently closed circular DNA genomeGerardo B Figueroa, Simmone D'souza, Higor S Pereira, et al.Hepatology (Baltimore, Md.)|February 3, 2015
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout miceDavor Slijepcevic, Christina Kaufman, Catharina G K Wichers, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2025
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis DeltaPietro Lampertico, Pavel O Bogomolov, Vladimir Chulanov, et al.Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.Pageof 23